Brief: HLS Therapeutics Announces Updates To Its Board Of Directors
22/06/2023 11:36
June 22 (Reuters) - HLS Therapeutics Inc HLS.TO :
* HLS THERAPEUTICS ANNOUNCES UPDATES TO ITS BOARD OF
DIRECTORS
* HLS THERAPEUTICS INC: JOHN WELBORN, JR. IS APPOINTED CHAIR
OF
BOARD, SUCCEEDING GREG GUBITZ, WHO IS RETIRING
* HLS THERAPEUTICS INC: JOHN HANNA IS APPOINTED TO HLS BOARD
AS AN
INDEPENDENT DIRECTOR
Source text for Eikon: ID:nCNW0tmmNa
Further company coverage: HLS.TO
((reuters.briefs@thomsonreuters.com;))
Recent news on HLS Therapeutics
See all newsCanada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group
Canada's HLS Therapeutics Q1 revenue rises on Vascepa growth, reaffirms 2026 guidance
Canada's HLS Therapeutics Q4 revenue slightly beats on Vascepa strength
Brief: Esperion Partner announces HLS Therapeutics received approval Of NILEMDO for the reduction of LDL-cholesterol in canadians at risk of cardiovascular disease
Brief: HLS Therapeutics announces Health Canada approval of NILEMDO for the reduction of LDL-Cholesterol in Canadians at risk of cardiovascular disease